These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33039674)

  • 1. Vitamin D - A host directed autophagy mediated therapy for tuberculosis.
    Periyasamy KM; Ranganathan UD; Tripathy SP; Bethunaickan R
    Mol Immunol; 2020 Nov; 127():238-244. PubMed ID: 33039674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The exploitation of host autophagy and ubiquitin machinery by
    Shariq M; Quadir N; Alam A; Zarin S; Sheikh JA; Sharma N; Samal J; Ahmad U; Kumari I; Hasnain SE; Ehtesham NZ
    Autophagy; 2023 Jan; 19(1):3-23. PubMed ID: 35000542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy: A new strategy for host-directed therapy of tuberculosis.
    Paik S; Kim JK; Chung C; Jo EK
    Virulence; 2019 Dec; 10(1):448-459. PubMed ID: 30322337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylbutyrate induces LL-37-dependent autophagy and intracellular killing of Mycobacterium tuberculosis in human macrophages.
    Rekha RS; Rao Muvva SS; Wan M; Raqib R; Bergman P; Brighenti S; Gudmundsson GH; Agerberth B
    Autophagy; 2015; 11(9):1688-99. PubMed ID: 26218841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate immunity to mycobacteria: vitamin D and autophagy.
    Jo EK
    Cell Microbiol; 2010 Aug; 12(8):1026-35. PubMed ID: 20557314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing host-pathogen interactions for innovative drug discovery and host-directed therapeutics to tackle tuberculosis.
    Saini S; Gangwar A; Sharma R
    Microbiol Res; 2023 Oct; 275():127466. PubMed ID: 37531813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Macrophage Response to
    Maphasa RE; Meyer M; Dube A
    Front Cell Infect Microbiol; 2020; 10():618414. PubMed ID: 33628745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MIR144* inhibits antimicrobial responses against Mycobacterium tuberculosis in human monocytes and macrophages by targeting the autophagy protein DRAM2.
    Kim JK; Lee HM; Park KS; Shin DM; Kim TS; Kim YS; Suh HW; Kim SY; Kim IS; Kim JM; Son JW; Sohn KM; Jung SS; Chung C; Han SB; Yang CS; Jo EK
    Autophagy; 2017 Feb; 13(2):423-441. PubMed ID: 27764573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis.
    Boland R; Heemskerk MT; Forn-Cuní G; Korbee CJ; Walburg KV; Esselink JJ; Carvalho Dos Santos C; de Waal AM; van der Hoeven DCM; van der Sar E; de Ries AS; Xie J; Spaink HP; van der Vaart M; Haks MC; Meijer AH; Ottenhoff THM
    mBio; 2023 Feb; 14(1):e0302422. PubMed ID: 36475748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tricks for old dogs: countering antibiotic resistance in tuberculosis with host-directed therapeutics.
    Hawn TR; Shah JA; Kalman D
    Immunol Rev; 2015 Mar; 264(1):344-62. PubMed ID: 25703571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host-Directed Therapeutic Strategies for Tuberculosis.
    Kolloli A; Subbian S
    Front Med (Lausanne); 2017; 4():171. PubMed ID: 29094039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy.
    Liu Y; Wang J; Yang J; Xia J; Yu J; Chen D; Huang Y; Yang F; Ruan Y; Xu JF; Pi J
    J Nanobiotechnology; 2024 Oct; 22(1):608. PubMed ID: 39379986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bazedoxifene Suppresses Intracellular Mycobacterium tuberculosis Growth by Enhancing Autophagy.
    Ouyang Q; Zhang K; Lin D; Feng CG; Cai Y; Chen X
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32269154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibrutinib suppresses intracellular mycobacterium tuberculosis growth by inducing macrophage autophagy.
    Hu Y; Wen Z; Liu S; Cai Y; Guo J; Xu Y; Lin D; Zhu J; Li D; Chen X
    J Infect; 2020 Jun; 80(6):e19-e26. PubMed ID: 32171871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy as an innate defense against mycobacteria.
    Jo EK
    Pathog Dis; 2013 Mar; 67(2):108-18. PubMed ID: 23620156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid induces antimicrobial peptides and cytokines leading to Mycobacterium tuberculosis elimination in airway epithelial cells.
    Jacobo-Delgado YM; Torres-Juarez F; Rodríguez-Carlos A; Santos-Mena A; Enciso-Moreno JE; Rivas-Santiago C; Diamond G; Rivas-Santiago B
    Peptides; 2021 Aug; 142():170580. PubMed ID: 34033876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loperamide Restricts Intracellular Growth of Mycobacterium tuberculosis in Lung Macrophages.
    Juárez E; Carranza C; Sánchez G; González M; Chávez J; Sarabia C; Torres M; Sada E
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):837-847. PubMed ID: 27468130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections.
    Heemskerk MT; Korbee CJ; Esselink JJ; Dos Santos CC; van Veen S; Gordijn IF; Vrieling F; Walburg KV; Engele CG; Dijkman K; Wilson L; Verreck FAW; Ottenhoff THM; Haks MC
    Sci Rep; 2021 Oct; 11(1):19634. PubMed ID: 34608194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory Mechanisms of Autophagy-Targeted Antimicrobial Therapeutics Against Mycobacterial Infection.
    Silwal P; Paik S; Kim JK; Yoshimori T; Jo EK
    Front Cell Infect Microbiol; 2021; 11():633360. PubMed ID: 33828998
    [No Abstract]   [Full Text] [Related]  

  • 20. Autophagy Induction as a Host-Directed Therapeutic Strategy against
    Adikesavalu H; Gopalaswamy R; Kumar A; Ranganathan UD; Shanmugam S
    Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34070995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.